Clinical efficacy, timing, and outcomes of ERCP for management of bile duct leaks: a nationwide cohort study

Abstract

Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) can safely and effectively manage postsurgical or traumatic bile duct leaks (BDLs). Standardized guidelines are lacking regarding effective management of BDLs. Our aim was to evaluate the efficacy, clinical outcomes, and complications of different ERCP techniques and intervention timing using a nationwide database.

Patients and methods We performed a retrospective analysis of the IBM Explorys database (1999–2019), a pooled, national, de-identified clinical database of over 64 million unique patients across the United States. ERCP timing after BDL was classified as emergent (< 1 day), urgent (1–3 days) or expectant (> 3 days). ERCP technique was classified into sphincterotomy, stent or combination therapy. ERCP complications were defined as pancreatitis, duodenal perforation, duodenal hemorrhage, and ascending cholangitis within 7 days of the procedure.

Results Expectant ERCP had a decreased risk of adverse events (AEs) compared to emergent and urgent ERCP (P = 0.004). Rehospitalization rates also were lower in expectant ERCP (P < 0.001). Patients with COPD were more likely to have an AE if the ERCP was performed emergently compared to expectantly (P = 0.002). Combination therapy had a lower rate of ERCP failure compared to placement of a biliary stent (P = 0.02). There was no statistically significant difference in rates of ERCP failure between biliary stent and sphincterotomy (P = 0.06) or sphincterotomy and combination therapy (P = 0.74).

Conclusion Our study suggests that ERCP does not need to be performed emergently or urgently for management of BDLs. Combination therapy is superior to stenting but not sphincterotomy; however, future prospective studies are needed to validate these findings.

Publication History

Received: 02 August 2020

Accepted: 22 October 2020

Article published online:
03 February 2021

• References

• 1 Adler DG, Papachristou GI, Taylor LJ. et al. Clinical outcomes in patients with bile leaks treated via ERCP with regard to the timing of ERCP: A large multicenter study. Gastrointest Endoscop 2017; 85: 766-772
• 2 Vlaemynck K, Lahousse L, Vanlander A. et al. Endoscopic management of biliary leaks: A systematic review with meta-analysis. Endoscopy 2019; 51: 1074-1081
• 3 Rainio M, Lindström O, Udd M. et al. Endoscopic therapy of biliary injury after cholecystectomy. Dig Dis Sci 2018; 63: 474-480
• 4 Abbas A, Sethi S, Brady P. et al. Endoscopic management of postcholecystectomy biliary leak: When and how? A nationwide study. . Gastrointest Endoscop 2019; 90: 233-241
• 5 Haidar H, Manasa E, Yassin K. et al. Endoscopic treatment of post-cholecystectomy bile leaks: a tertiary center experience. Surg Endosc 2020;
• 6 Chandra S, Murali AR, Masadeh M. et al. Comparison of biliary stent versus biliary sphincterotomy alone in the treatment of bile leak. Dig Dis 2020; 38: 32-37
• 7 Tanaka M, Takahata S, Konomi H. et al. Long-term consequence of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc 1998; 48: 465-469
• 8 Sugiyama M, Atomi Y. Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: long-term (more than 10 years) follow-up study. Am J Gastroenterol 2002; 97: 2763-2767
• 9 Pereira-Lima JC, Jakobs R, Winter UH. et al. Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc 1998; 48: 457-464
• 10 Sugiyama M, Atomi Y. Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis in young patients. Br J Surg 1998; 85: 917-921
• 11 Oliveira-Cunha M, Dennison AR, Garcea G. Late complications after endoscopic sphincterotomy. Surg Laparosc Endosc Percutan Tech 2016; 26: 1-5
• 12 Laursen SB, Leontiadis GI, Stanley AJ. et al. Relationship between timing of endoscopy and mortality in patients with peptic ulcer bleeding: a nationwide cohort study. Gastrointest Endosc 2017; 85: 936-944
• 13 Kumar NL, Cohen AJ, Nayor J. et al. Timing of upper endoscopy influences outcomes in patients with acute nonvariceal upper GI bleeding. Gastrointest Endosc 2017; 85: 945-952
• 14 Lau JYW, Yu Y, Tang RSY. et al. Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med 2020; 382: 1299-1308
• 15 Chathadi KV, Chandrasekhara V, Acosta RD. et al. The role of ERCP in benign diseases of the biliary tract. Gastrointest Endosc 2015; 81: 795-803
• 16 Dumonceau JM, Tringali A, Blero D. et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 2012; 44: 277-298
• 17 Explorys team. We unlock the power of BIG DATA to improve healthcare for everyone. Available at (Accessed November 23, 2019): https://www.ibm.com/watson/health/about/
• 18 Karb D, Mansoor E, Sravanthi Parasa GSC. Prevalence of diagnosed celiac disease and associated conditions in the United States between 2012–2017: Results form a national Electronic Patient Database. J Gastroenterol Hepatol Res 2019; 8: 2793-2799